Generation and function of astroglial lipoproteins from Niemann-Pick type C1-deficient mice.

NPC (Niemann-Pick type C) disease is a progressive neurological disorder characterized by defects in intracellular cholesterol trafficking, accumulation of cholesterol in the endosomal system and impaired cholesterol homoeostasis. Although these alterations appear to occur in all NPC1-deficient cell types, the consequences are most profound in the nervous system. Since glial cells are important mediators of brain cholesterol homoeostasis, we proposed that defective generation and/or function of lipoproteins released by glia might contribute to the neurological abnormalities associated with NPC disease. We found that, as in other cell types, Npc1-/- glia accumulate cholesterol intracellularly. We hypothesized that this sequestration of cholesterol in glia might restrict the availability of cholesterol for lipoprotein production. Cerebellar astroglia were cultured from a murine model of NPC disease to compare the lipoproteins generated by these cells and wild-type glia. The experiments demonstrate that the amount of cholesterol in glia-conditioned medium is not reduced by NPC1 deficiency. Similarly, cholesterol efflux to apo (apolipoprotein) A1 or glial expression of the transporter ATP-binding-cassette transporter A1 was not decreased by NPC1 deficiency. In addition, the ratio of apo E:cholesterol and the density distribution of lipoproteins in Npc1-/- and Npc1+/+ glia-conditioned medium are indistinguishable. Importantly, in a functional assay, apo E-containing lipoproteins generated by Npc1-/- and Npc1+/+ glia each stimulate axonal elongation of neurons by approx. 35%. On the basis of these observations, we speculate that the neuropathology characteristic of NPC disease can quite probably be ascribed to impaired processes within neurons in the brain rather than defective lipoprotein production by astroglia.

[1]  L. Bernier,et al.  Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain* , 2004, Journal of Biological Chemistry.

[2]  Steve Meaney,et al.  Brain Cholesterol: Long Secret Life Behind a Barrier , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[3]  R. Campenot,et al.  Glial Lipoproteins Stimulate Axon Growth of Central Nervous System Neurons in Compartmented Cultures* , 2004, Journal of Biological Chemistry.

[4]  Tony Wyss-Coray,et al.  Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice , 2004, The Journal of Neuroscience.

[5]  N. Mitsuda,et al.  l-Serine-mediated release of apolipoprotein E and lipids from microglial cells , 2004, Experimental Neurology.

[6]  Danielle A. Simmons,et al.  Postnatal development of inflammation in a murine model of Niemann–Pick type C disease: immunohistochemical observations of microglia and astroglia , 2003, Experimental Neurology.

[7]  G. Getz,et al.  Lipoproteins produced by ApoE–/– astrocytes infected with adenovirus expressing human ApoE , 2003, Journal of neurochemistry.

[8]  G. Francis,et al.  Impaired ABCA1-dependent Lipid Efflux and Hypoalphalipoproteinemia in Human Niemann-Pick type C Disease* , 2003, Journal of Biological Chemistry.

[9]  J. Crowley,et al.  NPC1 and NPC2 Regulate Cellular Cholesterol Homeostasis through Generation of Low Density Lipoprotein Cholesterol-derived Oxysterols* , 2003, Journal of Biological Chemistry.

[10]  J. Oram HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[11]  S. DeKosky,et al.  22R-Hydroxycholesterol and 9-cis-Retinoic Acid Induce ATP-binding Cassette Transporter A1 Expression and Cholesterol Efflux in Brain Cells and Decrease Amyloid β Secretion* , 2003, The Journal of Biological Chemistry.

[12]  R. Campenot,et al.  Trafficking of Cholesterol from Cell Bodies to Distal Axons in Niemann Pick C1-deficient Neurons* , 2003, The Journal of Biological Chemistry.

[13]  R. Campenot,et al.  Cholesterol accumulates in cell bodies, but is decreased in distal axons, of Niemann–Pick C1‐deficient neurons , 2002, Journal of neurochemistry.

[14]  Z. Balázs,et al.  ABCA1 and Scavenger Receptor Class B, Type I, Are Modulators of Reverse Sterol Transport at an in Vitro Blood-Brain Barrier Constituted of Porcine Brain Capillary Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[15]  K. Zou,et al.  Apolipoprotein E (ApoE) Isoform-dependent Lipid Release from Astrocytes Prepared from Human ApoE3 and ApoE4 Knock-in Mice* , 2002, The Journal of Biological Chemistry.

[16]  D. German,et al.  Neurodegeneration in the Niemann–Pick C mouse: glial involvement , 2002, Neuroscience.

[17]  W. Ong,et al.  Apolipoprotein D in the Niemann-Pick type C disease mouse brain: An ultrastructural immunocytochemical analysis , 2002, Journal of neurocytology.

[18]  C. Göritz,et al.  CNS synaptogenesis promoted by glia-derived cholesterol. , 2001, Science.

[19]  D. German,et al.  Degeneration of neurons and glia in the Niemann–Pick C mouse is unrelated to the low-density lipoprotein receptor , 2001, Neuroscience.

[20]  C. Buhmann,et al.  Characterization of four lipoprotein classes in human cerebrospinal fluid. , 2001, Journal of lipid research.

[21]  J. Dietschy,et al.  Cholesterol metabolism in the brain , 2001, Current opinion in lipidology.

[22]  R. Campenot,et al.  Uptake of Lipoproteins for Axonal Growth of Sympathetic Neurons* , 2000, The Journal of Biological Chemistry.

[23]  L. Henderson,et al.  Embryonic Striatal Neurons from Niemann-Pick Type C Mice Exhibit Defects in Cholesterol Metabolism and Neurotrophin Responsiveness* , 2000, The Journal of Biological Chemistry.

[24]  A. Fagan,et al.  Unique Lipoproteins Secreted by Primary Astrocytes From Wild Type, apoE (−/−), and Human apoE Transgenic Mice* , 1999, The Journal of Biological Chemistry.

[25]  E Schmutzhard,et al.  Increased Expression of Apolipoprotein D Following Experimental Traumatic Brain Injury , 1999, Journal of neurochemistry.

[26]  John Shelton,et al.  Reeler/Disabled-like Disruption of Neuronal Migration in Knockout Mice Lacking the VLDL Receptor and ApoE Receptor 2 , 1999, Cell.

[27]  S. Yokoyama,et al.  Differential Generation of High‐Density Lipoprotein by Endogenous and Exogenous Apolipoproteins in Cultured Fetal Rat Astrocytes , 1999, Journal of neurochemistry.

[28]  M. Vanier Lipid Changes in Niemann-Pick Disease Type C Brain: Personal Experience and Review of the Literature , 1999, Neurochemical Research.

[29]  R. Brady,et al.  Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Borg,et al.  Interaction of Cytosolic Adaptor Proteins with Neuronal Apolipoprotein E Receptors and the Amyloid Precursor Protein* , 1998, The Journal of Biological Chemistry.

[31]  A. Fagan,et al.  Potential role of apoE in structural plasticity in the nervous system; implications for disorders of the central nervous system. , 1998, Trends in cardiovascular medicine.

[32]  D. Holtzman,et al.  Nascent Astrocyte Particles Differ from Lipoproteins in CSF , 1998, Journal of neurochemistry.

[33]  Ramesh C. Patel,et al.  Cellular Cholesterol Storage in the Niemann‐Pick Disease Type C Mouse Is Associated with Increased Expression and Defective Processing of Apolipoprotein D , 1998, Journal of neurochemistry.

[34]  S. Yokoyama,et al.  Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. , 1997, Biochemistry.

[35]  W. Schneider,et al.  Novel members of the low density lipoprotein receptor superfamily and their potential roles in lipid metabolism , 1997, Current opinion in lipidology.

[36]  W. Pavan,et al.  Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. , 1997, Science.

[37]  K. G. Coleman,et al.  Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. , 1997, Science.

[38]  S. Vandenberg,et al.  Low density lipoprotein receptor-related protein is expressed early and becomes restricted to a somatodendritic domain during neuronal differentiation in culture , 1997, Brain Research.

[39]  R. James,et al.  Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. , 1995, Biochimica et biophysica acta.

[40]  R. Patel,et al.  Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. , 1995, Neuroreport.

[41]  Michaela Brenner Structure and Transcriptional Regulation of the GFAP Gene , 1994, Brain pathology.

[42]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[44]  T. Koeda,et al.  Type C Niemann-Pick disease Detection and quantification of cholesterol-accumulating cells in bone marrow , 1993, Brain and Development.

[45]  M. Eddleston,et al.  Molecular profile of reactive astrocytes—Implications for their role in neurologic disease , 1993, Neuroscience.

[46]  G. Handelmann,et al.  Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. , 1992, Journal of lipid research.

[47]  R. Brady,et al.  Niemann-Pick type-C disease: deficient intracellular transport of exogenously derived cholesterol. , 1992, American journal of medical genetics.

[48]  A. Chabás,et al.  [Type C Niemann-Pick disease]. , 1991, Sangre.

[49]  S. Young,et al.  Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. , 1991, The Journal of clinical investigation.

[50]  T. Bocan,et al.  Rapid on-line determination of cholesterol distribution among plasma lipoproteins after high-performance gel filtration chromatography. , 1991, Journal of lipid research.

[51]  L. Notterpek,et al.  Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. , 1990, The Journal of biological chemistry.

[52]  K. Cadigan,et al.  Isolation and characterization of Chinese hamster ovary cell mutants defective in intracellular low density lipoprotein-cholesterol trafficking , 1990, The Journal of cell biology.

[53]  H. Gassen,et al.  Synthesis of Apolipoprotein A‐1 in Pig Brain Microvascular Endothelial Cells , 1990, Journal of neurochemistry.

[54]  A. Kuksis,et al.  Molecular species of glycerophospholipids and sphingomyelins of human erythrocytes: Improved method of analysis , 1989, Lipids.

[55]  A. Kuksis,et al.  Molecular species of glycerophospholipids and sphingomyelins of human plasma: Comparison to red blood cells , 1989, Lipids.

[56]  L. Liscum,et al.  The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts , 1989, The Journal of cell biology.

[57]  E. Shooter,et al.  A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. , 1989, The Journal of clinical investigation.

[58]  David P. Corey,et al.  Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning , 1988, Neuron.

[59]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[60]  R. Brady,et al.  Type C Niemann-Pick disease. Lysosomal accumulation and defective intracellular mobilization of low density lipoprotein cholesterol. , 1988, The Journal of biological chemistry.

[61]  L. Liscum,et al.  Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick type C fibroblasts. , 1987, The Journal of biological chemistry.

[62]  R. E. Pitas,et al.  Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. , 1987, The Journal of biological chemistry.

[63]  R. Mahley,et al.  Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. , 1987, Biochimica et biophysica acta.

[64]  S. Yokoyama,et al.  The process of dissolving apolipoprotein A-I in an aqueous buffer. , 1982, Journal of biochemistry.

[65]  F. Pfrieger Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[66]  H. Bock,et al.  Lipoprotein receptors in the nervous system. , 2002, Annual review of biochemistry.

[67]  K. Goto,et al.  Human Apolipoprotein E Receptor 2 A NOVEL LIPOPROTEIN RECEPTOR OF THE LOW DENSITY LIPOPROTEIN RECEPTOR FAMILY PREDOMINANTLY EXPRESSED IN BRAIN* , 1996 .

[68]  C. Fielding,et al.  Evidence for the distribution of apolipoprotein E between lipoprotein classes in human normocholesterolemic plasma and for the origin of unassociated apolipoprotein E (Lp-E). , 1984, Journal of lipid research.